Global Brain Tumor Diagnosis and Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

SKU ID : QYR-21690137 | Publishing Date : 13-Sep-2022 | No. of pages : 113

Detailed TOC of Global Brain Tumor Diagnosis and Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 MRI
        1.2.3 CT Scan
        1.2.4 Tissue Sampling
        1.2.5 PET-CT Scan
        1.2.6 Cerebral Arteriogram
        1.2.7 Lumbar Puncture
        1.2.8 Molecular Testing
        1.2.9 EEG
    1.3 Market by Application
        1.3.1 Global Brain Tumor Diagnosis and Therapeutics Market Growth Rate by Application: 2017 VS 2021 VS 2028
        1.3.2 Surgery
        1.3.3 Radiation Therapy
        1.3.4 Chemotherapy
        1.3.5 Immunotherapy
        1.3.6 Targeted Therapy
    1.4 Study Objectives
    1.5 Years Considered
2 Market Perspective
    2.1 Global Brain Tumor Diagnosis and Therapeutics Market Size (2017-2028)
    2.2 Brain Tumor Diagnosis and Therapeutics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
    2.3 Global Brain Tumor Diagnosis and Therapeutics Market Size by Region (2017-2022)
    2.4 Global Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Region (2023-2028)
    2.5 Global Top Brain Tumor Diagnosis and Therapeutics Countries Ranking by Market Size
3 Brain Tumor Diagnosis and Therapeutics Competitive by Company
    3.1 Global Brain Tumor Diagnosis and Therapeutics Revenue by Players
        3.1.1 Global Brain Tumor Diagnosis and Therapeutics Revenue by Players (2017-2022)
        3.1.2 Global Brain Tumor Diagnosis and Therapeutics Market Share by Players (2017-2022)
    3.2 Global Brain Tumor Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Company Covered: Ranking by Brain Tumor Diagnosis and Therapeutics Revenue
    3.4 Global Brain Tumor Diagnosis and Therapeutics Market Concentration Ratio
        3.4.1 Global Brain Tumor Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Brain Tumor Diagnosis and Therapeutics Revenue in 2021
    3.5 Global Brain Tumor Diagnosis and Therapeutics Key Players Head office and Area Served
    3.6 Key Players Brain Tumor Diagnosis and Therapeutics Product Solution and Service
    3.7 Date of Enter into Brain Tumor Diagnosis and Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Global Brain Tumor Diagnosis and Therapeutics Breakdown Data by Type
    4.1 Global Brain Tumor Diagnosis and Therapeutics Historic Revenue by Type (2017-2022)
    4.2 Global Brain Tumor Diagnosis and Therapeutics Forecasted Revenue by Type (2023-2028)
5 Global Brain Tumor Diagnosis and Therapeutics Breakdown Data by Application
    5.1 Global Brain Tumor Diagnosis and Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Brain Tumor Diagnosis and Therapeutics Revenue by Company (2020-2022)
    6.2 North America Brain Tumor Diagnosis and Therapeutics Revenue by Type (2017-2028)
    6.3 North America Brain Tumor Diagnosis and Therapeutics Revenue by Application (2017-2028)
    6.4 North America Brain Tumor Diagnosis and Therapeutics Revenue by Country (2017-2028)
        6.4.1 U.S.
        6.4.2 Canada
7 Europe
    7.1 Europe Brain Tumor Diagnosis and Therapeutics Revenue by Company (2020-2022)
    7.2 Europe Brain Tumor Diagnosis and Therapeutics Revenue by Type (2017-2028)
    7.3 Europe Brain Tumor Diagnosis and Therapeutics Revenue by Application (2017-2028)
    7.4 Europe Brain Tumor Diagnosis and Therapeutics Revenue by Country (2017-2028)
        7.4.1 Germany
        7.4.2 France
        7.4.3 U.K.
        7.4.4 Italy
        7.4.5 Russia
8 Asia Pacific
    8.1 Asia Pacific Brain Tumor Diagnosis and Therapeutics Revenue by Company (2020-2022)
    8.2 Asia Pacific Brain Tumor Diagnosis and Therapeutics Revenue by Type (2017-2028)
    8.3 Asia Pacific Brain Tumor Diagnosis and Therapeutics Revenue by Application (2017-2028)
    8.4 Asia Pacific Brain Tumor Diagnosis and Therapeutics Revenue by Region (2017-2028)
        8.4.1 China
        8.4.2 Japan
        8.4.3 South Korea
        8.4.4 India
        8.4.5 Australia
        8.4.6 Taiwan
        8.4.7 Indonesia
        8.4.8 Thailand
        8.4.9 Malaysia
        8.4.10 Philippines
        8.4.11 Vietnam
9 Latin America
    9.1 Latin America Brain Tumor Diagnosis and Therapeutics Revenue by Company (2020-2022)
    9.2 Latin America Brain Tumor Diagnosis and Therapeutics Revenue by Type (2017-2028)
    9.3 Latin America Brain Tumor Diagnosis and Therapeutics Revenue by Application (2017-2028)
    9.4 Latin America Brain Tumor Diagnosis and Therapeutics Revenue by Country (2017-2028)
        9.4.1 Mexico
        9.4.2 Brazil
        9.4.3 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Brain Tumor Diagnosis and Therapeutics Revenue by Company (2020-2022)
    10.2 Middle East and Africa Brain Tumor Diagnosis and Therapeutics Revenue by Type (2017-2028)
    10.3 Middle East and Africa Brain Tumor Diagnosis and Therapeutics Revenue by Application (2017-2028)
    10.4 Middle East and Africa Brain Tumor Diagnosis and Therapeutics Revenue by Country (2017-2028)
        10.4.1 Turkey
        10.4.2 Saudi Arabia
        10.4.3 U.A.E
11 Company Profiles
    11.1 GE Healthcare
        11.1.1 GE Healthcare Company Details
        11.1.2 GE Healthcare Business Overview
        11.1.3 GE Healthcare Brain Tumor Diagnosis and Therapeutics Products and Services
        11.1.4 GE Healthcare Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.1.5 GE Healthcare Brain Tumor Diagnosis and Therapeutics SWOT Analysis
        11.1.6 GE Healthcare Recent Developments
    11.2 Hitachi
        11.2.1 Hitachi Company Details
        11.2.2 Hitachi Business Overview
        11.2.3 Hitachi Brain Tumor Diagnosis and Therapeutics Products and Services
        11.2.4 Hitachi Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.2.5 Hitachi Brain Tumor Diagnosis and Therapeutics SWOT Analysis
        11.2.6 Hitachi Recent Developments
    11.3 Philips Healthcare
        11.3.1 Philips Healthcare Company Details
        11.3.2 Philips Healthcare Business Overview
        11.3.3 Philips Healthcare Brain Tumor Diagnosis and Therapeutics Products and Services
        11.3.4 Philips Healthcare Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.3.5 Philips Healthcare Brain Tumor Diagnosis and Therapeutics SWOT Analysis
        11.3.6 Philips Healthcare Recent Developments
    11.4 Siemens Healthineers
        11.4.1 Siemens Healthineers Company Details
        11.4.2 Siemens Healthineers Business Overview
        11.4.3 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Products and Services
        11.4.4 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.4.5 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics SWOT Analysis
        11.4.6 Siemens Healthineers Recent Developments
    11.5 Toshiba Corporation
        11.5.1 Toshiba Corporation Company Details
        11.5.2 Toshiba Corporation Business Overview
        11.5.3 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Products and Services
        11.5.4 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.5.5 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics SWOT Analysis
        11.5.6 Toshiba Corporation Recent Developments
    11.6 Fujifilm Corporation
        11.6.1 Fujifilm Corporation Company Details
        11.6.2 Fujifilm Corporation Business Overview
        11.6.3 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Products and Services
        11.6.4 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.6.5 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics SWOT Analysis
        11.6.6 Fujifilm Corporation Recent Developments
    11.7 Shimadzu Corporation
        11.7.1 Shimadzu Corporation Company Details
        11.7.2 Shimadzu Corporation Business Overview
        11.7.3 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Products and Services
        11.7.4 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.7.5 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics SWOT Analysis
        11.7.6 Shimadzu Corporation Recent Developments
    11.8 Merck & Co.
        11.8.1 Merck & Co. Company Details
        11.8.2 Merck & Co. Business Overview
        11.8.3 Merck & Co. Brain Tumor Diagnosis and Therapeutics Products and Services
        11.8.4 Merck & Co. Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.8.5 Merck & Co. Brain Tumor Diagnosis and Therapeutics SWOT Analysis
        11.8.6 Merck & Co. Recent Developments
    11.9 AstraZeneca
        11.9.1 AstraZeneca Company Details
        11.9.2 AstraZeneca Business Overview
        11.9.3 AstraZeneca Brain Tumor Diagnosis and Therapeutics Products and Services
        11.9.4 AstraZeneca Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.9.5 AstraZeneca Brain Tumor Diagnosis and Therapeutics SWOT Analysis
        11.9.6 AstraZeneca Recent Developments
    11.10 Bristol Myer Squibb
        11.10.1 Bristol Myer Squibb Company Details
        11.10.2 Bristol Myer Squibb Business Overview
        11.10.3 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Products and Services
        11.10.4 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.10.5 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics SWOT Analysis
        11.10.6 Bristol Myer Squibb Recent Developments
    11.11 Novartis
        11.11.1 Novartis Company Details
        11.11.2 Novartis Business Overview
        11.11.3 Novartis Brain Tumor Diagnosis and Therapeutics Products and Services
        11.11.4 Novartis Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.11.5 Novartis Recent Developments
    11.12 Roche Diagnostics
        11.12.1 Roche Diagnostics Company Details
        11.12.2 Roche Diagnostics Business Overview
        11.12.3 Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Products and Services
        11.12.4 Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
        11.12.5 Roche Diagnostics Recent Developments
12 Brain Tumor Diagnosis and Therapeutics Market Dynamics
    12.1 Brain Tumor Diagnosis and Therapeutics Market Trends
    12.2 Brain Tumor Diagnosis and Therapeutics Market Drivers
    12.3 Brain Tumor Diagnosis and Therapeutics Market Challenges
    12.4 Brain Tumor Diagnosis and Therapeutics Market Restraints
13 Research Findings and Conclusion
14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details

List of Figures, Tables and Charts Available in Global Brain Tumor Diagnosis and Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

List of Tables
    Table 1. Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of MRI
    Table 3. Key Players of CT Scan
    Table 4. Key Players of Tissue Sampling
    Table 5. Key Players of PET-CT Scan
    Table 6. Key Players of Cerebral Arteriogram
    Table 7. Key Players of Lumbar Puncture
    Table 8. Key Players of Molecular Testing
    Table 9. Key Players of EEG
    Table 10. Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 11. Global Brain Tumor Diagnosis and Therapeutics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
    Table 12. Global Brain Tumor Diagnosis and Therapeutics Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Region (2017-2022)
    Table 14. Global Brain Tumor Diagnosis and Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Brain Tumor Diagnosis and Therapeutics Market Share by Players (2017-2022)
    Table 16. Global Top Brain Tumor Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Diagnosis and Therapeutics as of 2021)
    Table 17. Ranking of Global Top Brain Tumor Diagnosis and Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Brain Tumor Diagnosis and Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Brain Tumor Diagnosis and Therapeutics Product Solution and Service
    Table 21. Date of Key Manufacturers Enter into Brain Tumor Diagnosis and Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Brain Tumor Diagnosis and Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Type (2017-2022)
    Table 25. Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Type (2023-2028)
    Table 27. Global Brain Tumor Diagnosis and Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Application (2017-2022)
    Table 29. Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Application (2023-2028)
    Table 31. North America Brain Tumor Diagnosis and Therapeutics Revenue by Company (2020-2022) & (US$ Million)
    Table 32. North America Brain Tumor Diagnosis and Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 33. North America Brain Tumor Diagnosis and Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 34. North America Brain Tumor Diagnosis and Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 35. North America Brain Tumor Diagnosis and Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 36. North America Brain Tumor Diagnosis and Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 37. North America Brain Tumor Diagnosis and Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 38. Europe Brain Tumor Diagnosis and Therapeutics Revenue by Company (2020-2022) & (US$ Million)
    Table 39. Europe Brain Tumor Diagnosis and Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 40. Europe Brain Tumor Diagnosis and Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 41. Europe Brain Tumor Diagnosis and Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Europe Brain Tumor Diagnosis and Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Europe Brain Tumor Diagnosis and Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 44. Europe Brain Tumor Diagnosis and Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Brain Tumor Diagnosis and Therapeutics Revenue by Company (2020-2022) & (US$ Million)
    Table 46. Asia Pacific Brain Tumor Diagnosis and Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Brain Tumor Diagnosis and Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Brain Tumor Diagnosis and Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Brain Tumor Diagnosis and Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Brain Tumor Diagnosis and Therapeutics Revenue by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Brain Tumor Diagnosis and Therapeutics Revenue by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Brain Tumor Diagnosis and Therapeutics Revenue by Company (2020-2022) & (US$ Million)
    Table 53. Latin America Brain Tumor Diagnosis and Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 54. Latin America Brain Tumor Diagnosis and Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 55. Latin America Brain Tumor Diagnosis and Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 56. Latin America Brain Tumor Diagnosis and Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 57. Latin America Brain Tumor Diagnosis and Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 58. Latin America Brain Tumor Diagnosis and Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Revenue by Company (2020-2022) & (US$ Million)
    Table 60. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 64. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 65. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 66. GE Healthcare Company Details
    Table 67. GE Healthcare Business Overview
    Table 68. GE Healthcare Brain Tumor Diagnosis and Therapeutics Product and Services
    Table 69. GE Healthcare Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 70. GE Healthcare Brain Tumor Diagnosis and Therapeutics SWOT Analysis
    Table 71. GE Healthcare Recent Developments
    Table 72. Hitachi Company Details
    Table 73. Hitachi Business Overview
    Table 74. Hitachi Brain Tumor Diagnosis and Therapeutics Product and Services
    Table 75. Hitachi Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Hitachi Brain Tumor Diagnosis and Therapeutics SWOT Analysis
    Table 77. Hitachi Recent Developments
    Table 78. Philips Healthcare Company Details
    Table 79. Philips Healthcare Business Overview
    Table 80. Philips Healthcare Brain Tumor Diagnosis and Therapeutics Product and Services
    Table 81. Philips Healthcare Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 82. Philips Healthcare Brain Tumor Diagnosis and Therapeutics SWOT Analysis
    Table 83. Philips Healthcare Recent Developments
    Table 84. Siemens Healthineers Company Details
    Table 85. Siemens Healthineers Business Overview
    Table 86. Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Product and Services
    Table 87. Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 88. Siemens Healthineers Brain Tumor Diagnosis and Therapeutics SWOT Analysis
    Table 89. Siemens Healthineers Recent Developments
    Table 90. Toshiba Corporation Company Details
    Table 91. Toshiba Corporation Business Overview
    Table 92. Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Product and Services
    Table 93. Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 94. Toshiba Corporation Brain Tumor Diagnosis and Therapeutics SWOT Analysis
    Table 95. Toshiba Corporation Recent Developments
    Table 96. Fujifilm Corporation Company Details
    Table 97. Fujifilm Corporation Business Overview
    Table 98. Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Product and Services
    Table 99. Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 100. Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics SWOT Analysis
    Table 101. Fujifilm Corporation Recent Developments
    Table 102. Shimadzu Corporation Company Details
    Table 103. Shimadzu Corporation Business Overview
    Table 104. Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Product and Services
    Table 105. Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 106. Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics SWOT Analysis
    Table 107. Shimadzu Corporation Recent Developments
    Table 108. Merck & Co. Company Details
    Table 109. Merck & Co. Business Overview
    Table 110. Merck & Co. Brain Tumor Diagnosis and Therapeutics Product and Services
    Table 111. Merck & Co. Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 112. Merck & Co. Brain Tumor Diagnosis and Therapeutics SWOT Analysis
    Table 113. Merck & Co. Recent Developments
    Table 114. AstraZeneca Company Details
    Table 115. AstraZeneca Business Overview
    Table 116. AstraZeneca Brain Tumor Diagnosis and Therapeutics Product and Services
    Table 117. AstraZeneca Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 118. AstraZeneca Brain Tumor Diagnosis and Therapeutics SWOT Analysis
    Table 119. AstraZeneca Recent Developments
    Table 120. Bristol Myer Squibb Company Details
    Table 121. Bristol Myer Squibb Business Overview
    Table 122. Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Product and Services
    Table 123. Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 124. Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics SWOT Analysis
    Table 125. Bristol Myer Squibb Recent Developments
    Table 126. Novartis Company Details
    Table 127. Novartis Business Overview
    Table 128. Novartis Brain Tumor Diagnosis and Therapeutics Product and Services
    Table 129. Novartis Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 130. Novartis Recent Developments
    Table 131. Roche Diagnostics Company Details
    Table 132. Roche Diagnostics Business Overview
    Table 133. Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Product and Services
    Table 134. Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2017-2022) & (US$ Million)
    Table 135. Roche Diagnostics Recent Developments
    Table 136. Brain Tumor Diagnosis and Therapeutics Market Trends
    Table 137. Brain Tumor Diagnosis and Therapeutics Market Drivers
    Table 138. Brain Tumor Diagnosis and Therapeutics Market Challenges
    Table 139. Brain Tumor Diagnosis and Therapeutics Market Restraints
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Type: 2021 VS 2028
    Figure 2. MRI Features
    Figure 3. CT Scan Features
    Figure 4. Tissue Sampling Features
    Figure 5. PET-CT Scan Features
    Figure 6. Cerebral Arteriogram Features
    Figure 7. Lumbar Puncture Features
    Figure 8. Molecular Testing Features
    Figure 9. EEG Features
    Figure 10. Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Application: 2021 VS 2028
    Figure 11. Surgery Case Studies
    Figure 12. Radiation Therapy Case Studies
    Figure 13. Chemotherapy Case Studies
    Figure 14. Immunotherapy Case Studies
    Figure 15. Targeted Therapy Case Studies
    Figure 16. Brain Tumor Diagnosis and Therapeutics Report Years Considered
    Figure 17. Global Brain Tumor Diagnosis and Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 18. Global Brain Tumor Diagnosis and Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 19. Global Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Region: 2021 VS 2028
    Figure 20. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Region in 2017 VS 2022
    Figure 21. Global Top 10 Brain Tumor Diagnosis and Therapeutics Countries Ranking by Market Size (US$ Million) in 2021
    Figure 22. Global Brain Tumor Diagnosis and Therapeutics Market Share by Players in 2021
    Figure 23. Global Top Brain Tumor Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Diagnosis and Therapeutics as of 2021)
    Figure 24. The Top 10 and 5 Players Market Share by Brain Tumor Diagnosis and Therapeutics Revenue in 2021
    Figure 25. North America Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Company in 2021
    Figure 26. North America Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 27. North America Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 28. North America Brain Tumor Diagnosis and Therapeutics Revenue Share by Country (2017-2028)
    Figure 29. U.S. Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 30. Canada Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 31. Europe Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Company in 2021
    Figure 32. Europe Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 33. Europe Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 34. Europe Brain Tumor Diagnosis and Therapeutics Revenue Share by Country (2017-2028)
    Figure 35. Germany Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 36. France Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 37. U.K. Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 38. Italy Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 39. Russia Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 40. Asia Pacific Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Company in 2021
    Figure 41. Asia Pacific Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 42. Asia Pacific Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 43. Asia Pacific Brain Tumor Diagnosis and Therapeutics Revenue Share by Region (2017-2028)
    Figure 44. China Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 45. Japan Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 46. South Korea Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 47. India Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 48. Australia Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 49. Taiwan Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 50. Indonesia Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 51. Thailand Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 52. Malaysia Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 53. Philippines Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 54. Vietnam Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 55. Latin America Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Company in 2021
    Figure 56. Latin America Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 57. Latin America Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 58. Latin America Brain Tumor Diagnosis and Therapeutics Revenue Share by Country (2017-2028)
    Figure 59. Mexico Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 60. Brazil Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 61. Argentina Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 62. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Company in 2021
    Figure 63. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 64. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 65. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Revenue Share by Country (2017-2028)
    Figure 66. Turkey Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 67. Saudi Arabia Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 68. U.A.E Brain Tumor Diagnosis and Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 69. GE Healthcare Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 70. Hitachi Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 71. Philips Healthcare Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 72. Siemens Healthineers Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 73. Toshiba Corporation Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 74. Fujifilm Corporation Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 75. Shimadzu Corporation Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 76. Merck & Co. Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 77. AstraZeneca Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 78. Bristol Myer Squibb Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 79. Novartis Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 80. Roche Diagnostics Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2017-2022)
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed

Keyplayers in Global Brain Tumor Diagnosis and Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

GE Healthcare
Hitachi
Philips Healthcare
Siemens Healthineers
Toshiba Corporation
Fujifilm Corporation
Shimadzu Corporation
Merck & Co.
AstraZeneca
Bristol Myer Squibb
Novartis
Roche Diagnostics

REQUEST SUMMARY

Request Sample

Pre-order Enquiry

Request Discount

Contact Information

24/7 Research Support

Phone: +1 424 253 0807

[email protected]